Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 22, Issue S1, Pages 16-31
Publisher
Wiley
Online
2020-04-08
DOI
10.1111/dom.13969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs
- (2019) Himanshu Sankrityayan et al. PHARMACOLOGICAL RESEARCH
- Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy
- (2019) Hanan H. Ahmed et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
- (2019) Jonatan Barrera-Chimal et al. KIDNEY INTERNATIONAL
- Cell surface expression of 78 kDa glucose regulated protein (GRP78) mediates diabetic nephropathy
- (2019) Richard Van Krieken et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
- (2019) Yanhuan Feng et al. American Journal of Cardiovascular Drugs
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
- (2019) Hiddo J. L. Heerspink et al. DIABETOLOGIA
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons
- (2019) Javier Donate-Correa et al. Journal of Clinical Medicine
- Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial
- (2019) Kenneth W. Mahaffey et al. CIRCULATION
- Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
- (2019) Annabelle M. Warren et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Long Non-Coding RNAs in Kidney Disease
- (2019) Michael Ignarski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1 induced gene expression in mesangial cells and diabetic kidney
- (2019) Ye Jia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease
- (2019) Jeong Suk Kang et al. Scientific Reports
- Cytosine Methylation Studies in Patients with Diabetic Kidney Disease
- (2019) Tamas Aranyi et al. Current Diabetes Reports
- Effects of Selonsertib in Patients with Diabetic Kidney Disease
- (2019) Glenn M. Chertow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
- (2019) Sun et al. MOLECULES
- The single-cell transcriptomic landscape of early human diabetic nephropathy
- (2019) Parker C. Wilson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- Use of Paricalcitol as Adjunctive Therapy to Renin-Angiotensin-Aldosterone System Inhibition for Diabetic Nephropathy: A Systematic Review of the Literature
- (2019) Alexandra Schuster et al. CLINICAL THERAPEUTICS
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
- (2019) Erik J.M. van Bommel et al. KIDNEY INTERNATIONAL
- Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease
- (2019) Dou et al. Toxins
- Acute Kidney Injury and Progression of Diabetic Kidney Disease
- (2018) Samuel Mon-Wei Yu et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- SGLT2 inhibition and kidney protection
- (2018) Josselin Nespoux et al. CLINICAL SCIENCE
- Cannabinoid Receptors in Diabetic Kidney Disease
- (2018) F. Barutta et al. Current Diabetes Reports
- Incretins and Lipid Metabolism
- (2018) Vasilis Tsimihodimos et al. CURRENT MEDICINAL CHEMISTRY
- Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
- (2018) Juan F. Navarro-González et al. DIABETES CARE
- Development of SGLT1 and SGLT2 inhibitors
- (2018) Timo Rieg et al. DIABETOLOGIA
- Effects of incretin-based therapies on renal function
- (2018) Vasilis Tsimihodimos et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Update of pathophysiology and management of diabetic kidney disease
- (2018) Yi-Chih Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury
- (2018) Quan Hong et al. KIDNEY INTERNATIONAL
- Advanced glycation end products in the pathogenesis of chronic kidney disease
- (2018) Naila Rabbani et al. KIDNEY INTERNATIONAL
- CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
- (2018) Hans-Joachim Anders et al. Nature Reviews Nephrology
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes
- (2018) Netanya Y. Spencer et al. PLoS One
- Paricalcitol and albuminuria: tread carefully
- (2018) Beatriz Fernandez-Fernandez et al. Lancet Diabetes & Endocrinology
- Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial
- (2018) Aneliya Parvanova et al. Lancet Diabetes & Endocrinology
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- REVERSAL OF ALBUMINURIA BY COMBINED AM6545 AND PERINDOPRIL THERAPY IN EXPERIMENTAL DIABETIC NEPHROPATHY
- (2018) F Barutta et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting AMPK in Diabetes and Diabetic Complications: Energy homeostasis, Autophagy and Mitochondrial health
- (2018) Y. V. Madhavi et al. CURRENT MEDICINAL CHEMISTRY
- Glucagon-Like Peptide-1 and its Cleavage Products are Renoprotective in Murine Diabetic Nephropathy
- (2018) Moellmann Julia et al. DIABETES
- Sodium glucose cotransporter 2 inhibition and renal ischemia: implications for future clinical trials
- (2018) Daniël H. van Raalte et al. KIDNEY INTERNATIONAL
- Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy
- (2018) Dan-Dan Qiu et al. CHINESE MEDICAL JOURNAL
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
- (2018) Sandor Koszegi et al. JOURNAL OF PHYSIOLOGY-LONDON
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats
- (2018) Weiqin Yin et al. Journal of Diabetes Investigation
- SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wnt signaling and podocyte dysfunction in diabetic nephropathy
- (2017) Madhura Bose et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy
- (2017) Liad Hinden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease
- (2017) Steven G. Coca et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats
- (2017) Lin Li et al. Molecular Medicine Reports
- Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy
- (2017) Federica Barutta et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
- (2017) Qidi Ying et al. RENAL FAILURE
- The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1
- (2017) Li Xiao et al. Redox Biology
- Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis
- (2017) Davide Bolignano et al. PLoS One
- Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy
- (2017) Shan-Shan Huang et al. Scientific Reports
- Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic rats
- (2017) Szabina Czirok et al. Scientific Reports
- Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy
- (2017) Hengjiang Guo et al. Scientific Reports
- Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy
- (2016) Hang Yuan et al. ANTIOXIDANTS & REDOX SIGNALING
- Hydrogen Sulfide in Renal Physiology and Disease
- (2016) Denis Feliers et al. ANTIOXIDANTS & REDOX SIGNALING
- Endothelin-1 and the kidney
- (2016) Carmen De Miguel et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
- (2016) Pierre-Jean Saulnier et al. DIABETES
- Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
- (2016) Margien G.S. Boels et al. DIABETES
- Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
- (2016) Asma S. AL-Onazi et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
- (2016) M. Garsen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- H2S improves renal fibrosis in STZ-induced diabetic rats by ameliorating TGF-β1 expression
- (2016) Yan Li et al. RENAL FAILURE
- An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy
- (2016) Mitsuo Kato et al. Nature Communications
- The Role of Hydrogen Sulfide in Renal System
- (2016) Xu Cao et al. Frontiers in Pharmacology
- Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial
- (2015) Katherine R. Tuttle et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Spironolactone Add-on for Preventing or Slowing the Progression of Diabetic Nephropathy: A Meta-analysis
- (2015) Jing Hou et al. CLINICAL THERAPEUTICS
- Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes
- (2015) E. J. Swan et al. DIABETIC MEDICINE
- Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat
- (2015) Sabbir Khan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes Induces Aberrant DNA Methylation in the Proximal Tubules of the Kidney
- (2015) T. Marumo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis
- (2015) XIN-YI SUN et al. Molecular Medicine Reports
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
- (2015) Zeng Si Wang et al. BMC Nephrology
- Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study
- (2015) Seung Jin Han et al. Diabetology & Metabolic Syndrome
- Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)
- (2015) Sudha K. Iyengar et al. PLoS Genetics
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- Endothelin Blockade in Diabetic Kidney Disease
- (2015) Lidia Anguiano et al. Journal of Clinical Medicine
- Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
- (2014) Amy Jayne McKnight et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications
- (2014) Merlin C. Thomas ADVANCES IN CHRONIC KIDNEY DISEASE
- Correlation of Lower Concentrations of Hydrogen Sulfide with Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy
- (2014) Han Li et al. BLOOD PURIFICATION
- Advanced glycation end product accumulation
- (2014) Sandeep K. Mallipattu et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
- (2014) Keizo Kanasaki et al. DIABETES
- Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease
- (2014) S. M. Tan et al. DIABETES
- Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats
- (2014) Sabbir Khan et al. FOOD AND CHEMICAL TOXICOLOGY
- Role of endoplasmic reticulum stress in apoptosis of differentiated mouse podocytes induced by high glucose
- (2014) YANPING CAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model
- (2014) Xiang Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy?
- (2014) Aowen Zhuang et al. JOURNAL OF ENDOCRINOLOGY
- Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy
- (2014) Yuliya Sharkovska et al. JOURNAL OF HYPERTENSION
- Direct Action of Endothelin-1 on Podocytes Promotes Diabetic Glomerulosclerosis
- (2014) O. Lenoir et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
- (2014) J. C. Jha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC Study
- (2014) M. R. Wing et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Effect of Add-on Pentoxifylline on Proteinuria in Membranous Glomerulonephritis: A 6-month Placebo-controlled Trial
- (2013) Shirinsadat Badri et al. CLINICAL DRUG INVESTIGATION
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
- (2013) K. Yamahara et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- H2S Inhibits Hyperglycemia-Induced Intrarenal Renin-Angiotensin System Activation via Attenuation of Reactive Oxygen Species Generation
- (2013) Hong Xue et al. PLoS One
- The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice
- (2013) Sih Min Tan et al. PLoS One
- Endothelin antagonists for diabetic and non-diabetic chronic kidney disease
- (2012) Donald E. Kohan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes
- (2012) Lilla Fang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade
- (2012) Ina M. Ott et al. PLoS One
- Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism
- (2011) Andrew Advani et al. AMERICAN JOURNAL OF PATHOLOGY
- The proximal tubule in the pathophysiology of the diabetic kidney
- (2011) Volker Vallon AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy
- (2011) T. Zhou et al. DIABETOLOGIA
- Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes
- (2011) Karly C. Sourris et al. FREE RADICAL BIOLOGY AND MEDICINE
- Wnt/β-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival
- (2011) Hideki Kato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
- (2010) Sara Giunti et al. Current Vascular Pharmacology
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes
- (2010) Dilip K. Deb et al. KIDNEY INTERNATIONAL
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats
- (2008) Kyung-Hwan Jeong et al. AMERICAN JOURNAL OF NEPHROLOGY
- Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease
- (2008) Guanghui Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
- (2008) Z. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search